MEP6708A - Derivati n/tiayol/2/yl/benyamida - Google Patents

Derivati n/tiayol/2/yl/benyamida

Info

Publication number: MEP6708A
Authority: ME; Montenegro
Prior art keywords: thiazol; benzamide derivatives; agonists; receptor; implicated
Prior art date: 2003-10-27

Application number

MEP-67/08A

Other languages

Bosnian (bs)

English (en)

Inventor

Anette Graven Sams

Mogens Larsen

Gitte Mikkelsen

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-10-27

Filing date

2004-10-25

Publication date

2010-02-10

2004-10-25 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2010-02-10 Publication of MEP6708A publication Critical patent/MEP6708A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

MEP-67/08A 2003-10-27 2004-10-25 Derivati n/tiayol/2/yl/benyamida MEP6708A (xx)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DKPA200301579		2003-10-27
DKPA200400229		2004-02-13
PCT/DK2004/000733 WO2005039572A1 (fr)	2003-10-27	2004-10-25	Derives de n-thiazole-2-yle-benzamide

Publications (1)

Publication Number	Publication Date
MEP6708A true MEP6708A (xx)	2010-02-10

Family

ID=34524309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-67/08A MEP6708A (xx)	2003-10-27	2004-10-25	Derivati n/tiayol/2/yl/benyamida

Country Status (28)

Country	Link
US (2)	US20060154974A1 (fr)
EP (2)	EP1682129B1 (fr)
JP (1)	JP2007509083A (fr)
KR (1)	KR20060093726A (fr)
AR (1)	AR047621A1 (fr)
AT (1)	ATE354365T1 (fr)
AU (1)	AU2004283019A1 (fr)
BR (1)	BRPI0415661A (fr)
CA (1)	CA2542816A1 (fr)
CO (1)	CO5690582A2 (fr)
CY (1)	CY1106526T1 (fr)
DE (1)	DE602004004925T2 (fr)
DK (1)	DK1682129T3 (fr)
EA (2)	EA200801734A1 (fr)
ES (1)	ES2279414T3 (fr)
HR (1)	HRP20070194T3 (fr)
IL (1)	IL175189A0 (fr)
IS (1)	IS8364A (fr)
ME (1)	MEP6708A (fr)
MX (1)	MXPA06004436A (fr)
NO (1)	NO20062417L (fr)
PL (1)	PL1682129T3 (fr)
PT (1)	PT1682129E (fr)
RS (1)	RS20060289A (fr)
SG (1)	SG147472A1 (fr)
SI (1)	SI1682129T1 (fr)
TW (1)	TW200524887A (fr)
WO (1)	WO2005039572A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060106040A1 (en)	2002-12-19	2006-05-18	Michael Grzelak	Adenosine A2a receptor antagonists for the treatment of extra-pyramidal syndrome and other movement disorders
TW200524887A (en) *	2003-10-27	2005-08-01	Lundbeck & Co As H	N-thiazol-2-yl-benzamide derivatives
WO2006032273A1 (fr)	2004-09-22	2006-03-30	H. Lundbeck A/S	Derives de 2-acylaminothiazole
TW200720264A (en) *	2005-04-25	2007-06-01	Lundbeck & Co As H	Pro-drugs of n-thiazol-2-yl-benzamide derivatives
US7674912B2 (en)	2005-04-25	2010-03-09	H. Lundbeck A/S	Pro-drugs of N-thiazol-2-yl-benzamide derivatives
JPWO2006137527A1 (ja) *	2005-06-23	2009-01-22	協和発酵キリン株式会社	チアゾール誘導体
SI1921077T1 (sl)	2005-08-02	2017-11-30	Kyowa Hakko Kirin Co., Ltd.	Sredstvo za zdravljenje in/ali preprečevanje motnje spanja
ES2273599B1 (es)	2005-10-14	2008-06-01	Universidad De Barcelona	Compuestos para el tratamiento de la fibrilacion auricular.
EP2210891A1 (fr) *	2009-01-26	2010-07-28	Domain Therapeutics	Nouveaux ligands du récepteur de l'adénosine et leurs utilisations
GB201106817D0 (en)	2011-04-21	2011-06-01	Astex Therapeutics Ltd	New compound
RU2483722C1 (ru) *	2012-05-22	2013-06-10	Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан"	Аминотиазольные производные усниновой кислоты как новые противотуберкулезные агенты
GB201218862D0 (en)	2012-10-19	2012-12-05	Astex Therapeutics Ltd	Bicyclic heterocycle compounds and their uses in therapy
GB201218864D0 (en)	2012-10-19	2012-12-05	Astex Therapeutics Ltd	Bicyclic heterocycle compounds and their uses in therapy
GB201218850D0 (en)	2012-10-19	2012-12-05	Astex Therapeutics Ltd	Bicyclic heterocycle compounds and their uses in therapy
US9980973B2 (en)	2012-10-19	2018-05-29	Astex Therapeutics Limited	Bicyclic heterocycle compounds and their uses in therapy
LT3083616T (lt)	2013-12-20	2021-09-10	Astex Therapeutics Limited	Bicikinių heterociklų junginiai ir jų panaudojimas terapijoje
ES2578363B1 (es) *	2015-01-22	2017-01-31	Palobiofarma, S.L.	Moduladores de los receptores A3 de adenosina

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE855120C (de) *	1950-10-08	1953-01-05	Schering Ag	Verfahren zur Herstellung von Aminosalicylsaeureamiden
JP2903339B2 (ja) *	1990-10-12	1999-06-07	大日精化工業株式会社	電子写真感光体
ES2191202T3 (es) *	1996-10-24	2003-09-01	Zeria Pharm Co Ltd	Derivados de benzoilaminotiazol sustituidos y medicamentos que los contienen.
GB9823871D0 (en) *	1998-10-30	1998-12-23	Pharmacia & Upjohn Spa	2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
GB0028383D0 (en) *	2000-11-21	2001-01-03	Novartis Ag	Organic compounds
MXPA03006510A (es) *	2001-01-26	2003-10-15	Shionogi & Co	Compuestos halogenados que muestran agonismo del receptor de trombopoyetina.
US7429593B2 (en) *	2001-09-14	2008-09-30	Shionogi & Co., Ltd.	Utilities of amide compounds
US6624163B2 (en) *	2001-11-29	2003-09-23	Hoffman-La Roche Inc.	Benzothiazole derivatives
US6713499B2 (en) *	2001-12-12	2004-03-30	Hoffman-La Roche Inc.	7-Amino-benzothiazole derivatives
TW200524887A (en) *	2003-10-27	2005-08-01	Lundbeck & Co As H	N-thiazol-2-yl-benzamide derivatives
PL1700856T3 (pl) *	2003-12-26	2016-05-31	Kyowa Hakko Kirin Co Ltd	Pochodna tiazolu
US7674912B2 (en) *	2005-04-25	2010-03-09	H. Lundbeck A/S	Pro-drugs of N-thiazol-2-yl-benzamide derivatives

2004
- 2004-10-08 TW TW093130498A patent/TW200524887A/zh unknown
- 2004-10-21 AR ARP040103822A patent/AR047621A1/es not_active Application Discontinuation
- 2004-10-25 EA EA200801734A patent/EA200801734A1/ru unknown
- 2004-10-25 RS YUP-2006/0289A patent/RS20060289A/sr unknown
- 2004-10-25 JP JP2006535952A patent/JP2007509083A/ja not_active Withdrawn
- 2004-10-25 DK DK04762951T patent/DK1682129T3/da active
- 2004-10-25 DE DE602004004925T patent/DE602004004925T2/de not_active Expired - Fee Related
- 2004-10-25 SG SG200807988-1A patent/SG147472A1/en unknown
- 2004-10-25 ES ES04762951T patent/ES2279414T3/es not_active Expired - Lifetime
- 2004-10-25 HR HR20070194T patent/HRP20070194T3/xx unknown
- 2004-10-25 CA CA002542816A patent/CA2542816A1/fr not_active Abandoned
- 2004-10-25 ME MEP-67/08A patent/MEP6708A/xx unknown
- 2004-10-25 EP EP04762951A patent/EP1682129B1/fr not_active Expired - Lifetime
- 2004-10-25 WO PCT/DK2004/000733 patent/WO2005039572A1/fr not_active Ceased
- 2004-10-25 AU AU2004283019A patent/AU2004283019A1/en not_active Abandoned
- 2004-10-25 EA EA200600860A patent/EA010790B1/ru not_active IP Right Cessation
- 2004-10-25 AT AT04762951T patent/ATE354365T1/de not_active IP Right Cessation
- 2004-10-25 EP EP07102639A patent/EP1803455A1/fr not_active Withdrawn
- 2004-10-25 MX MXPA06004436A patent/MXPA06004436A/es active IP Right Grant
- 2004-10-25 KR KR1020067008181A patent/KR20060093726A/ko not_active Ceased
- 2004-10-25 PT PT04762951T patent/PT1682129E/pt unknown
- 2004-10-25 PL PL04762951T patent/PL1682129T3/pl unknown
- 2004-10-25 BR BRPI0415661-7A patent/BRPI0415661A/pt not_active IP Right Cessation
- 2004-10-25 SI SI200430225T patent/SI1682129T1/sl unknown
2005
- 2005-12-20 US US11/312,661 patent/US20060154974A1/en not_active Abandoned
2006
- 2006-03-20 IS IS8364A patent/IS8364A/is unknown
- 2006-04-25 CO CO06039105A patent/CO5690582A2/es not_active Application Discontinuation
- 2006-04-25 IL IL175189A patent/IL175189A0/en unknown
- 2006-05-26 NO NO20062417A patent/NO20062417L/no not_active Application Discontinuation
2007
- 2007-04-19 CY CY20071100529T patent/CY1106526T1/el unknown
2008
- 2008-12-19 US US12/339,438 patent/US20090247593A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RS20060289A (sr)	2008-06-05
KR20060093726A (ko)	2006-08-25
SG147472A1 (en)	2008-11-28
PL1682129T3 (pl)	2007-07-31
PT1682129E (pt)	2007-04-30
BRPI0415661A (pt)	2006-12-19
DE602004004925T2 (de)	2007-10-31
EA200801734A1 (ru)	2008-12-30
EP1682129B1 (fr)	2007-02-21
HRP20070194T3 (hr)	2007-06-30
CY1106526T1 (el)	2012-01-25
MXPA06004436A (es)	2006-06-20
WO2005039572A1 (fr)	2005-05-06
EP1803455A1 (fr)	2007-07-04
ATE354365T1 (de)	2007-03-15
AR047621A1 (es)	2006-02-01
NO20062417L (no)	2006-05-26
US20060154974A1 (en)	2006-07-13
CA2542816A1 (fr)	2005-05-06
JP2007509083A (ja)	2007-04-12
TW200524887A (en)	2005-08-01
IS8364A (is)	2006-03-20
EA200600860A1 (ru)	2006-08-25
AU2004283019A1 (en)	2005-05-06
EP1682129A1 (fr)	2006-07-26
CO5690582A2 (es)	2006-10-31
US20090247593A1 (en)	2009-10-01
SI1682129T1 (sl)	2007-06-30
DK1682129T3 (da)	2007-06-11
ES2279414T3 (es)	2007-08-16
IL175189A0 (en)	2006-09-05
EA010790B1 (ru)	2008-10-30
DE602004004925D1 (de)	2007-04-05

Publication	Publication Date	Title
MEP6708A (xx)	2010-02-10	Derivati n/tiayol/2/yl/benyamida
TW200503710A (en)	2005-02-01	Novel compounds
NO20054404L (no)	2005-11-24	5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon
TNSN07272A1 (en)	2008-12-31	Substituted bis aryl and heteroaryl compounds as selective 5ht 2a antagonists
MY135841A (en)	2008-07-31	Novel benzodioxoles
ATE384050T1 (de)	2008-02-15	Benzazepinderivate als histamin-h3-antagonisten
GB0325956D0 (en)	2003-12-10	Novel compounds
NZ544591A (en)	2009-07-31	Pyrrolodihydroisoquinolines as PDE10 inhibitors
ATE512957T1 (de)	2011-07-15	Hemmer der akt aktivität
MXPA05010652A (es)	2005-12-12	Pirazoles sustituidos.
MXPA05002442A (es)	2005-09-30	Imidazolopiridinas y metodos para la elaboracion y uso de las mismas.
TW200503713A (en)	2005-02-01	Novel compounds
MXPA05010630A (es)	2005-12-12	Compuestos de benzopirano utiles para tratar estados inflamatorios.
MXPA05011707A (es)	2006-02-13	Dihidroquinazolinas sustituidas con propiedades antivirales.
MX2007000505A (es)	2007-06-25	Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
MXPA05002443A (es)	2005-09-30	Pirazolopiridinas y metodos para elaboracion y uso de las mismas.
MXPA05007115A (es)	2005-11-16	Nuevos agonistas inversos del receptor cb 1.
WO2004030620A3 (fr)	2004-06-10	Inhibiteurs de tyrosine kinase
MXPA05011962A (es)	2006-02-02	Oxiarenos substituidos.
ZA200404752B (en)	2005-04-26	6-aminomorphinane derivatives method for the production and use thereof
TW200514781A (en)	2005-05-01	Novel compounds
MXPA04006266A (es)	2004-09-27	Pirimidotriazinas como inhibidores de fosfatasa.
NO20072060L (no)	2007-04-23	2-acylaminotiazolderivater
DE50201565D1 (de)	2004-12-23	2-thio-subsituierte imidazolderivative und ihre verwendung in der pharmazie
GB0412314D0 (en)	2004-07-07	Compounds